GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Return-on-Tangible-Asset

Beijing Tiantan Biological Products (SHSE:600161) Return-on-Tangible-Asset : 9.55% (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Beijing Tiantan Biological Products's annualized Net Income for the quarter that ended in Mar. 2024 was ¥1,267 Mil. Beijing Tiantan Biological Products's average total tangible assets for the quarter that ended in Mar. 2024 was ¥13,260 Mil. Therefore, Beijing Tiantan Biological Products's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 was 9.55%.

The historical rank and industry rank for Beijing Tiantan Biological Products's Return-on-Tangible-Asset or its related term are showing as below:

SHSE:600161' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 0.18   Med: 8.74   Max: 22.07
Current: 8.97

During the past 13 years, Beijing Tiantan Biological Products's highest Return-on-Tangible-Asset was 22.07%. The lowest was 0.18%. And the median was 8.74%.

SHSE:600161's Return-on-Tangible-Asset is ranked better than
93.29% of 1550 companies
in the Biotechnology industry
Industry Median: -40.42 vs SHSE:600161: 8.97

Beijing Tiantan Biological Products Return-on-Tangible-Asset Historical Data

The historical data trend for Beijing Tiantan Biological Products's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Return-on-Tangible-Asset Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.58 9.87 8.53 7.80 8.95

Beijing Tiantan Biological Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.66 9.74 9.84 6.76 9.55

Competitive Comparison of Beijing Tiantan Biological Products's Return-on-Tangible-Asset

For the Biotechnology subindustry, Beijing Tiantan Biological Products's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tiantan Biological Products's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Beijing Tiantan Biological Products's Return-on-Tangible-Asset falls into.



Beijing Tiantan Biological Products Return-on-Tangible-Asset Calculation

Beijing Tiantan Biological Products's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=1109.889/( (11825.236+12963.659)/ 2 )
=1109.889/12394.4475
=8.95 %

Beijing Tiantan Biological Products's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2024 )  (Q: Dec. 2023 )(Q: Mar. 2024 )
=1266.696/( (12963.659+13556.812)/ 2 )
=1266.696/13260.2355
=9.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2024) net income data.


Beijing Tiantan Biological Products  (SHSE:600161) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Beijing Tiantan Biological Products Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tiantan Biological Products (SHSE:600161) Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.
Executives
Wang Jian Ming Supervisors
Liu Ya Na Directors, senior managers
Fu Dao Xing Directors, senior managers
He Yan Lin Directors, senior managers
Hu Li Gang Director
Ci Xiang senior management
Yang Hui Chuan Director
Zhang Yi senior management
Wu Zhen Shan senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines